经口手术与放疗作为老年HPV相关口咽癌初始治疗的比较
这项回顾性队列研究利用美国国家癌症数据库(NCDB)纳入2566例cT1-2期HPV相关口咽鳞状细胞癌老年患者,比较初始经口手术(TOS)与初始放疗(RT)的肿瘤学结局。倾向性评分匹配后,初始TOS组5年总生存率(81.6%;95%CI:79.6%-83.6%)高于初始RT组(70.7%;95%CI:68.3%-73.1%),校正风险比(HR)为0.64(95%CI:0.50-0.81;p<0.001)。2020年确诊患者中仅13.6%接受初始TOS,且研究期间呈显著下降趋势。
要点
- 倾向性评分匹配后,初始TOS组5年OS为81.6%,初始RT组为70.7%,校正HR为0.64(95%CI:0.50-0.81;p<0.001)。
- 2566例cT1-2期HPV相关口咽鳞状细胞癌老年患者中,73.9%接受初始RT,22.3%接受初始TOS。
- 2020年确诊患者中仅13.6%接受初始TOS,研究期间初始TOS使用呈显著下降趋势。
核心结论
- 本研究提示,对于老年HPV相关口咽鳞状细胞癌患者,初始经口手术可能较初始放疗提供更好的生存结局。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库(NCDB)中cT1-2期HPV相关口咽鳞状细胞癌患者数据。
- 共纳入2566例患者,其中73.9%接受初始放疗,22.3%接受初始经口手术。
主要发现
- 倾向性评分匹配后,初始经口手术组5年总生存率为81.6%(95%CI:79.6%-83.6%),初始放疗组为70.7%(95%CI:68.3%-73.1%)。
- 校正后风险比(HR)为0.64(95%CI:0.50-0.81;p<0.001),初始经口手术组较初始放疗组风险降低。
- 2020年确诊患者中仅13.6%接受初始经口手术,研究期间初始经口手术使用呈显著下降趋势。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study compares the oncological outcomes of primary transoral surgery (TOS) and primary radiotherapy (RT) in elderly patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC). METHODS: This retrospective cohort study included patients with cT1-2 HPV-related OPSCC from the National Cancer Database (NCDB). RESULTS: A total of 2566 patients were included, with 73.9% receiving primary RT and 22.3% undergoing primary TOS. Subgroup analysis showed a higher 5-year overall survival (OS) rate for primary TOS (81.6%; 95% CI: 79.6%-83.6%) compared to primary RT (70.7%; 95% CI: 68.3%-73.1%), with an adjusted hazard ratio (HR) of 0.64 (95% CI: 0.50-0.81; p < 0.001) after propensity score matching. Notably, only (13.6%) of patients diagnosed in 2020 underwent primary TOS, with a significant decline over the study period. CONCLUSIONS: This study suggests that primary TOS may offer better survival outcomes for elderly patients with HPV-related OPSCC compared to primary RT.
引用
- Costantino A, Haughey B, Zhu J, et al. Transoral Surgery Versus Radiotherapy as Primary Treatment for HPV-Related Oropharyngeal Cancer in the Elderly. Head Neck. 2025. PMID: 39917816. doi:10.1002/hed.28097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。